penicillamine has been researched along with Dysphagia in 5 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When compared to patients prescribed donepezil, galantamine, or memantine, individuals prescribed rivastigmine were almost twice as likely to report dysphagia as an adverse event." | 8.12 | Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System. ( Bu, K; Cheng, F; Han, W; Morris, R; Patel, D; Umeukeje, G; Zhu, T, 2022) |
| "When compared to patients prescribed donepezil, galantamine, or memantine, individuals prescribed rivastigmine were almost twice as likely to report dysphagia as an adverse event." | 4.12 | Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System. ( Bu, K; Cheng, F; Han, W; Morris, R; Patel, D; Umeukeje, G; Zhu, T, 2022) |
| "We conclude that Wilson's disease may be a good indication for LTX for both neurological manifestation with stable liver function and hepatic manifestation with cirrhosis or acute liver failure." | 1.30 | Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease. ( Bechstein, WO; Becker, M; Luck, W; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Schuelke, M; Schumacher, G; Steinmüller, T, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, K | 1 |
| Patel, D | 1 |
| Morris, R | 1 |
| Han, W | 1 |
| Umeukeje, G | 1 |
| Zhu, T | 1 |
| Cheng, F | 1 |
| McCann, P | 1 |
| Pramanik, A | 1 |
| Schumacher, G | 1 |
| Platz, KP | 1 |
| Mueller, AR | 1 |
| Neuhaus, R | 1 |
| Steinmüller, T | 1 |
| Bechstein, WO | 1 |
| Becker, M | 1 |
| Luck, W | 1 |
| Schuelke, M | 1 |
| Neuhaus, P | 1 |
| Barrera, P | 1 |
| den Broeder, AA | 1 |
| van den Hoogen, FH | 1 |
| van Engelen, BG | 1 |
| van de Putte, LB | 1 |
| François, J | 1 |
| Verbraeken, H | 1 |
| Gabriel, P | 1 |
| Wille, C | 1 |
5 other studies available for penicillamine and Dysphagia
| Article | Year |
|---|---|
Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Clozapine | 2022 |
Dysphagia and unexpected myasthenia gravis associated with primary biliary cirrhosis, ulcerative colitis and vitiligo.
Topics: Aged; Colitis, Ulcerative; Deglutition Disorders; Humans; Liver Cirrhosis, Biliary; Male; Myasthenia | 2004 |
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Topics: Adolescent; Adult; Anemia, Hemolytic; Ataxia; Chelating Agents; Deglutition Disorders; Dysarthria; D | 1997 |
Postural changes, dysphagia, and systemic sclerosis.
Topics: Antirheumatic Agents; Deglutition Disorders; Diagnosis, Differential; Histocompatibility Testing; Hu | 1998 |
[Myasthenic syndrome following oral treatment with penicillamine].
Topics: Arthritis, Rheumatoid; Blepharoptosis; Deglutition Disorders; Diplopia; Female; Humans; Middle Aged; | 1978 |